Intravenous Thrombolytic Treatment of Acute Ischemic Stroke Associated with Left Atrial Myxoma : A Case Report
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-02-01
著者
-
Etienne Mill
Department Of Neurology Neurological Institute Columbia University Medical Center
-
SHERMAN David
Department of Biomechanical Engineering, the Johns Hopkins University School of Medicine
-
Sherman David
Department Of Biomechanical Engineering The Johns Hopkins University School Of Medicine
-
Sherman David
Department Of Medicine Neurological Institute Columbia University Medical Center
-
CHONG Ji
Department of Neurology, Neurological Institute, Columbia University Medical Center
-
VRANIAK Peter
College of Physicians and Surgeons, Neurological Institute, Columbia University Medical Center
-
ELKIND Mitchell
Department of Neurology, Neurological Institute, Columbia University Medical Center
-
Chong Ji
Department Of Neurology Neurological Institute Columbia University Medical Center
-
Vraniak Peter
College Of Physicians And Surgeons Neurological Institute Columbia University Medical Center
-
Elkind Mitchell
Department Of Neurology College Of Physicians And Surgeons Columbia University And The Columbia Univ
-
Elkind Mitchell
Department Of Neurology Neurological Institute Columbia University Medical Center
関連論文
- Target-specific Catecholamine Elevation Induced by Anticonvulsant Thalamic Deep Brain Stimulation
- Intravenous Thrombolytic Treatment of Acute Ischemic Stroke Associated with Left Atrial Myxoma : A Case Report
- Leukocyte Count Predicts Outcome After Ischemic Stroke : The Northern Manhattan Stroke Study
- On the Structure of Isometries between Noncommutative $L^p$ Spaces
- Anterior Thalamic Mediation of Experimental Seizures : Selective EEG Spectral Coherence
- Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism After Acute Ischemic Stroke : Rationale, Design, and Methods of an Open-Label, Randomized, Parallel-Group Multicenter Trial
- Prevention of Venous Thromboembolism, Recurrent Stroke, and Other Vascular Events After Acute Ischemic Stroke : The Role of Low-Molecular-Weight Heparin and Antiplatelet Therapy